Clinical Trials
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
Pfizer Inc. and BioNTech SE announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior...
Drug Research
Thermo Fisher Scientific and Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China
Thermo Fisher Scientific Inc., the world leader in serving science, and Innoforce, a bioinnovation-enabling company, announced they have signed a joint venture agreement to...
News
CDMOs benefit from COVID-19 impacts but mega-cap pharma innovation slowing outsourcing according to CPhI Annual Report
The global contact services sector is benefiting from a switch towards COVID-19 manufacturing (vaccine and therapy) and clinical stage contracts, but mega-cap innovator drug...
Clinical Trials
Pfizer Announces Positive Phase 3 Study Results for XELJANZ in Ankylosing Spondylitis
Pfizer Inc. announced positive results from a Phase 3 investigational study evaluating the safety and efficacy of tofacitinib in adults with active ankylosing spondylitis...
Press Releases
AmerisourceBergen Reaches agreement with US CDC to support independent retail pharmacies access to COVID-19 vaccine
AmerisourceBergen has reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC) to include Good Neighbor Pharmacy and Elevate Provider Network...
News
Lonza Celebrates the Grand Opening of a New Facility for ADC Payload Manufacturing
Lonza, a specialty CDMO partner to the biopharma industry, today inaugurated the first of two manufacturing suites for antibody-drug conjugate (ADC) drug-linker (payload) manufacturing...
News
ACG Invests in Mumbai-Based start-up contract research organization IQGEN-X
Supplier of integrated pharmaceutical manufacturing solutions, ACG, has revealed in a Nov. 3, 2020 press release, that it has acquired a significant stake in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read